|
Delbeke D, Martin WH. Update of PET and PET/CT for hepatobiliary and pancreatic malignancies. HPB, 7, 166-179, 2005 Roman CD, Martin WH, Delbeke D. Incremental value of fusion imaging with integrated PET-CT in oncology. Clin Nucl Med, 30, 470-477, 2005 Roman, CD, Habibian, MR, Martin, WH. Identification of an infected left ventricular assist device after cardiac
transplant by indium-111 WBC scintigraphy. Clin Nucl Med, 30(1), 16-7, 2005 Roman, CD, Martin, WH, Delbeke, D. Incremental value of fusion imaging with integrated PET-CT in oncology. Clin Nucl Med, 30(7), 470-7, 2005 Delbeke, D, Martin, WH. Metabolic imaging with FDG: a primer. Cancer J, 10(4), 201-13, 2004 Delbeke, D, Martin, WH. PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med, 34(3), 209-23, 2004 Pereira Neto, CC, Roman, C, Johnson, M, Jagasia, M, Martin, WH, Delbeke, D. Positron emission tomography/computed tomography of a rare xanthogranulomatous
process: Erdheim-Chester disease. Mol Imaging Biol, 6(1), 63-7, 2004 Scanga, DR, Martin, WH, Delbeke, D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine,
and neural crest tumors. Clin Nucl Med, 29(2), 86-90, 2004 Scarfone, C, Lavely, WC, Cmelak, AJ, Delbeke, D, Martin, WH, Billheimer, D, Hallahan, DE. Prospective feasibility trial of radiotherapy target definition for head and
neck cancer using 3-dimensional PET and CT imaging. J Nucl Med, 45(4), 543-52, 2004 Tharp, K, Israel, O, Hausmann, J, Bettman, L, Martin, WH, Daitzchman, M, Sandler, MP, Delbeke, D. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up
of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging, 31(10), 1435-42, 2004 Bacharach SL, Bax JJ, Case J, Delbeke D, Martin WH. PET myocardial glucose metabolism and perfusion imaging. Part I: Guidelines for data acquisition and patient preparation. J Nucl Cardiol, 10(), 543-556, 2003 Goldstein RE, Billheimer D, Martin WH, Richards K. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg, 237(5), 722-31, 2003 Ludwig, V, Fordice, S, Lamar, R, Martin, WH, Delbeke, D. Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron
emission tomography and bone scintigraphy. Clin Nucl Med, 28(3), 176-9, 2003 Ludwig, V, Hopper, OW, Martin, WH, Kikkawa, R, Delbeke, D. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic
metastases from prostate cancer following radiofrequency ablation: a case report. Am Surg, 69(7), 593-8, 2003 Ludwig, V, Martin, WH, Delbeke, D. Calcium channel blockers: a potential cause of false-positive captopril renography. Clin Nucl Med, 28(2), 108-12, 2003 Scarfone C, Lavely WC, Cmelak AJ, Delbeke D, Martin WH, Billheimer D, Hallahan DE. Quantification of molecular and anatomical target contours of head and neck cancer to facilitate image-guided therapy during IMRT. Int J Radiat Oncol Biol Phys, 57 (2 Suppl), S300-1, 2003 Delbeke, D, Martin, WH, Morgan, DS, Kinney, MC, Feurer, I, Kovalsky, E, Arrowsmith, T, Greer, JP. 2-deoxy-2-[F-18]fluoro-D-glucose imaging with positron emission tomography
for initial staging of Hodgkin's disease and lymphoma. Mol Imaging Biol, 4(1), 105-14, 2002 Komori, T, Martin, WH, Graber, AL, Delbeke, D. Serendipitous detection of Cushing's disease by FDG positron emission tomography
and a review of the literature. Clin Nucl Med, 27(3), 176-8, 2002 Ludwig, V, Komori, T, Kolb, D, Martin, WH, Sandler, MP, Delbeke, D. Cerebral lesions incidentally detected on 2-deoxy-2-[18F]fluoro-D-glucose positron
emission tomography images of patients evaluated for body malignancies. Mol Imaging Biol, 4(5), 359-62, 2002 Ludwig, V, Rice, MH, Martin, WH, Kelley, MC, Delbeke, D. 2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in a giant
adrenal myelolipoma. Mol Imaging Biol, 4(5), 355-8, 2002 Delbeke, D, Martin, WH. Positron emission tomography imaging in oncology. Radiol Clin North Am, 39(5), 883-917, 2001 Delbeke, D, Martin, WH, Patton, JA, Sandler, MP. Value of iterative reconstruction, attenuation correction, and image fusion
in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based
attenuation maps. Radiology, 218(1), 163-71, 2001 Hallahan DE, Geng L, Cmelak AJ, Chakravarthy A, Martin WH, Scarfone C, Gonzalez A. Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature. J Control Release, 74, 183-191, 2001 Hallahan DE, Qu S, Geng L, Cmelak A, Chakravarthy A, Martin WH, Scarfone C, Giorgio T. Radiation-mediated control of drug delivery. Am J Clin Oncol, 24, 473-480, 2001 Molpus KL, Kelley MC, Johnson JE, Martin WH, Jones HW 3rd. Sentinel lymph node detection and microstaging in vulvar carcinoma. J Reprod Med, 46(10), 863-9, 2001 Goldstein RE, Martin WH, Richards K. Minimally inasive radioguided parathyroidectomy (MIRP). Minerva Chir, 58, 269-79, 2000 Goldstein, RE, Blevins, L, Delbeke, D, Martin, WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length
of stay, and costs in the management of primary hyperparathyroidism. Ann Surg, 231(5), 732-42, 2000 Teller RE, Christie MJ, Martin WH, Nance EP, Haas DW. Sequential indium-labeled leukocyte and bone scans to diagnose prosthetic joint infection. Clinical Orthopaedics and Related Res, 373, 241-247, 2000 Delbeke, D, Patton, JA, Martin, WH, Sandler, MP. FDG PET and dual-head gamma camera positron coincidence detection imaging of
suspected malignancies and brain disorders. J Nucl Med, 40(1), 110-7, 1999 Delbeke, D, Martin, WH, Sandler, MP, Chapman, WC, Wright, JK, Pinson, CW. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg, 133(5), 510-5; discussion 515-6, 1998 Martin, WH. Eventration of the diaphragm on radionuclide ventriculography. Clin Nucl Med, 23(9), 625-6, 1998 Sandler, MP, Bax, JJ, Patton, JA, Visser, FC, Martin, WH, Wijns, W. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation
camera. J Nucl Med, 39(12), 2035-43, 1998 Martin, WH, Jones, RC, Delbeke, D, Sandler, MP. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose
cardiac single-photon emission tomography. Eur J Nucl Med, 24(10), 1291-7, 1997 Peeler, BB, Martin, WH, Sandler, MP, Goldstein, RE. Sestamibi parathyroid scanning and preoperative localization studies for patients
with recurrent/persistent hyperparathyroidism or significant comorbid conditions: development of an optimal
localization strategy. Am Surg, 63(1), 37-46, 1997 Anthony LB, Martin WH, Delbeke D, Sandler MP. Somatostatin receptor imaging: predictive and prognostic considerations. Digestion, 57 (Suppl 1), 50-53, 1996 Martin, WH, Delbeke, D, Patton, JA, Sandler, MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Radiology, 198(1), 225-31, 1996 Delbeke D, Videlefsky S, Campbell MG, Patton JA, Martin WH, Ohana I, Sandler MP. Evaluation of myocardial viability with simultaneous rest perfusion/metabolism dual isotope imaging using Tc-99m-MIBI and FDG SPECT. J Nucl Med, 36, 2110-2119, 1995 Delbeke, D, Videlefsky, S, Patton, JA, Campbell, MG, Martin, WH, Ohana, I, Sandler, MP. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope
acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG. J Nucl Med, 36(11), 2110-9, 1995 Martin W, Delbeke D, Patton JA, Sandler MP. F-18 FDG SPECT: Correlation with F-18 FDG PET. J Nucl Med, 36, 988-995, 1995 Martin, WH, Delbeke, D, Patton, JA, Hendrix, B, Weinfeld, Z, Ohana, I, Kessler, RM, Sandler, MP. FDG-SPECT: correlation with FDG-PET. J Nucl Med, 36(6), 988-95, 1995 Sandler, MP, Videlefsky, S, Delbeke, D, Patton, JA, Meyerowitz, C, Martin, WH, Ohana, I. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion
protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition
single-photon emission computed tomography. J Am Coll Cardiol, 26(4), 870-8, 1995 |